Intestinal resection-associated metabolic syndrome
- PMID: 29588076
- PMCID: PMC5994370
- DOI: 10.1016/j.jpedsurg.2018.02.077
Intestinal resection-associated metabolic syndrome
Abstract
Background: Short bowel syndrome occurs following massive small bowel resection (SBR) and is one of the most lethal diseases of childhood. We have previously demonstrated hepatic steatosis, altered gut microbiome, and increased fat deposition in our murine model of SBR. These novel findings prompted us to investigate potential alterations in glucose metabolism and systemic inflammation following intestinal resection.
Methods: Male C57BL6 mice underwent 50% proximal SBR or sham operation. Body weight and composition were measured. Fasting blood glucose (FBG), glucose, and insulin tolerance testing were performed. Small bowel, pancreas, and serum were collected at sacrifice and analyzed.
Results: SBR mice gained less weight than shams after 10weeks. Despite this, FBG in resected mice was significantly higher than sham animals. After SBR, mice demonstrated perturbed body composition, higher blood glucose, increased pancreatic islet area, and increased systemic inflammation compared with sham mice. Despite these changes, we found no alteration in insulin tolerance after resection.
Conclusions: After massive SBR, we present evidence for abnormal body composition, glucose metabolism, and systemic inflammation. These findings, coupled with resection-associated hepatic steatosis, suggest that massive SBR (independent of parenteral nutrition) results in metabolic consequences not previously described and provides further evidence to support the presence of a novel resection-associated metabolic syndrome.
Keywords: Hepatic steatosis; Short bowel syndrome; Small bowel resection.
Copyright © 2018 Elsevier Inc. All rights reserved.
Figures





References
-
- Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology. 2006;130:S70–77. - PubMed
-
- Pichler J, Chomtho S, Fewtrell M, et al. Body composition in paediatric intestinal failure patients receiving long-term parenteral nutrition. Arch Dis Child. 2014;99:147–153. - PubMed
-
- Olieman JF, Penning C, Spoel M, et al. Long-term impact of infantile short bowel syndrome on nutritional status and growth. Br J Nutr. 2012;107:1489–1497. - PubMed
-
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812–819. - PubMed
-
- Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–1778. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical